Hemostasis and dental treatment;Hemostasia y tratamiento odontológico

Avances en Odontoestomatologia

Volumn 20, Issue 5, 2004, Pages 247-261

  Quintero Parada, Eduardo ^a,b   Sabater Recolons, M M ^a   Chimenos Kustner, E ^a   Lopez Lopez J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NONE   (Spain)

Author keywords

C10tting factors; Dental treatment; Hemostasis

Indexed keywords

EID: 61849086392     PISSN: 02131285     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. 1. Catalano P.Trastornos hemostáticos. En: Roce L, Kaye D, editores. Medicina Interna en Odontología. 1 ed. Barcelona: Salvat; 1992. p. 431-65.
2. BermudoAñino L, Gutierres JL. Manejo del paciente con trastornos hemorrágicos. En: BermudoAñino L, Palma Gómez de la casa A, editores. Tratamiento del paciente odontológico con hemopatías. Madrid: Glaxo-Smith-LilineIntigraf; 2001. p. 39-54.
3. Silvestre Donat FJ. Alteraciones de la hemostasia. En: Bagán Sebastián JV, Ceballos Salobreña JV, Bermejo Fenoll A, Aguirre Urízar JM, Peñarrocha Diago M, editores. Medicina Oral. 1 ed. Barcelona: Masson; 1995. p. 618-23.
4. Guyton AC. Hemostasia y Coagulación de la sangre. En: Guyton AC, Hall JE, editores. Tratado de Fisiología Médica. 10 ed. Madrid: McGrawHill. lnteraméricana.; 2002. p. 509-21.
5. Cutando A, Gil-Montoya JA. El paciente dental con alteraciones de la hemostasia. Revisión de la fisiopatología de la hemostasia para odontólogos. Med Oral 1999;4:485-93.
6. Castillo Cofiño R, Ordinas Bauzá A, Reverter Calatayud JC, Vicente García V,Rocha Hernando E, Martínez-Brotons F. Enfermedades de la hemostasia. En: Farreras Valentí P, Rozman C, editores. Medicina Interna. Madrid: Harcourt; 2000. p. 2001-48.
7. Gallardo Castillo I, Ríos Santos JV, Bullón Fernández P.Manifestaciones Orales de las alteraciones de la Hemostasia. En: Ceballos Salobreña JV, Bullón Fernández P,Gándara Rey JM, Chimenos Kustner E, Blanco Carrión A, Martínez-Sahuquillo Márquez A, et al., editores. Medicina Bucal Práctica. 1 ed. Santiago de Compostela: Asoprogaio; 2000. p. 597-610.
8. Jansson JH, Boman K, Brannstrom M, Nilsson TK. High concentration of thrombomodulin in plasma is associated with hemorrhage: a prospective study in patients receiving long term anticoagulant treatment. Circulation 1997;96:2938-43.
9. Gresele P, Momi S, Berrettini M, Nenci GG, Scwarz Hp, Semeraro M, et al. Activated protein C prevents thrombin induced thromboembolism in mice. Evidence that activated protein C reduces intravacular fibrin accumulation through the inhibition of aditional thrombin generation. J Clin invest 1998; 101: 667-76.
10. Joseph R. Introducción a los trastornos hematológicos. En: Roce L, Kaye D, editores. Medicina interna en odontología. Barcelona: Salvat; 1992. p. 343-8.
11. González R, Lozano ML, Moraleda JM. Trastornos de la hemostasia primaria. En: Moraleda JM, editor. Hematolgía. 2 ed. Madrid: Luzán 5, S.A; 1996. p. 471-85.
12. Martínez-Sahuquillo Márquez A. Manifestaciones Orales de las enfermedades hematológicas. En: Bascones Martínez A, editor. Tratado de odontología. Madrid: Smithkline Beecham; 1998. p. 3173-80.
13. García García A. Tumores benignos de la cavidad oral. En: Bascones Martínez A, editor. Tratado de odontología. Madrid: Smithkline Beecham; 1998. p. 3966.
14. Philip Sapp J, Evercole L, GP W Patología oral y maxilofacial contemporánea. En. Madrid: Harcourt; 1998. p. 406-15.
15. Sabba C, Pasculli G, Cirulli A, Gallitelli M, Virgilio G, Resta F, et al. Hereditary hemorrhagic teleangiectasia (Rendu-Osler-Weber disease). Minerva Cardioangiol 2002; 50: 221-38.
16. Barak S, Katz J, Kaplan I. The C02 laser in surgery of vascular tumors of the oral cavity in children. J Dent Child 1991; 58: 293-6.
17. Schardt-Sacco D. Update on coagulopathies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 90: 559-63.
18. Sonbol H, Pelargidou M, Lucas VS, Gelbier MJ, Mason C, Roberts GJ. Dental health indices and caries-related microflora in children with severe haemophilia. Haemophilia 2001;7: 468-74.
19. Kleinman MB. Anti-inhibitor coagulant complex for the rescue therapy of acquired inhibitors to factor VIII: case report and review of the Iiterature. Haemophilia 2002; 8: 694-7.
20. Goedert JJ, Eyster ME, Lederman MM, Mandalaki T, De Moerloose p, White GC, 2nd, et al. End-stage Iiver disease in persons with hemophilia and transfusion-associated infections. Blood 2002; 100: 1584-9.
21. Diamondstone LS, Aledort LM, Goedert JJ. Factors predictive of death among HIV-uninfected persons with haemophilia and other congenital coagulation disorders. Haemophilia 2002; 8: 660- 7.
22. Scully C, Cawson R. Haemorrhagic Disorders. En: Medical Problems in Dentistry. 3era ed. Great Britain: Butterworth-Heinemann; 1993. p. 82105.
23. Mokhtari H, Roosendaal G, Koole R, Mauser-Bunschoten EP, van den Berg HM. [Oral surgery in hemophilia patients]. Ned Tijdschr Tandheelkd 2003; 110: 74-7.
24. Ehl S, Severin T, Sutor AH. DDAVP (desmopressin; 1-deamino-cys-8-D- arginine-vasopressin) treatment in children with haemophilia B. Br J Haematol2000; 111: 1260-2. 260/AVANCES EN ODONTOESTOMATOLOGíA
25. Zanon E, Martinelli F, Bacci e, Zerbinati p, Girolami A. Proposal of a standard approach to dental extraction in haemophilia patients. A casecontrol study with good results. Haemophilia 2000; 6: 533-6.
26. Bodner L, Weinstein J, Kleiner A. Efficacy of fibrin sealent in patients on various levels of oral anticoagulant undergoing oral surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86: 421-3.
27. Stubbs M, Lloyd J. A protocol for the dental management of von WiIlebrand's disease, haemophilia A and haemophilia B. Aust Dent J 2001; 46: 37-40.
28. Sadler J, Mannucci P, Berntorp E, et al. Impact, diagnosis and treatment of von WiIlebrand disease. Thromb Haemost 2000; 84: 160-74.
29. Mannucci PM. How I treat patients with von Willebrand disease. Blood 2001; 97: 1915-9.
30. Veiga P, Caballro Barrigón M. Enfermedades hemorrágicas por alteraciones de la coagulación. En: Veiga P, editor. Pediatría. 1era ed. Madrid: Egraf; 1995. p. 649-55.
31. Mannucci P. Hemostatic drugs. N Engl J Med 1998; 339: 245-53.
32. Kaufmann J, Okshe A, Wollheim C, Gunther G, Rosenthal W, Vischer U. Vasopressin-induced von WiIlebrand factor secretion form endhotelial cells involves V2 receptors and cAMP. J Clin Invest 2000; 106: 107-16.
33. Mannucci P, Canciani M, Rota L, Donovan B. Response of factor VIII/von WiIlebrand factor to DDAVP in healthy subjects and patients with ha emophilia A and von WiIlebrand disease. Br J Haematol1981; 47: 283-93.
34. Mannucci P, Ruggeri Z, Pareti F, Capitanio A. Deamino-8-D-arginine vasopressin: a new pharmacological apprach to the manegement of haemophilia and von WiIlebrand disease. Lancet 1977; 1: 869-72.
35. Mannucci P. Desmopressin (DDAVP)in the treatment of bleeding disorders: the first 20 years. Blood 1997; 90: 2515-21.
36. Leissinger C, Becton D, Cornell C, Jr., Cox Giu J. High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A. Haemophilia 2001; 7: 258-66.
37. DeClerck D, Vinckier F, Vermylen J. Influence of anticoagulation on blood loss following dental extractions. J Dent Res 1992; 71: 387-90.
38. Bailey B, Fordyce A. Complications of dental extracctions in paitents receiving warfarina anticoagulant therapy: a controlledclinical trial. Br Dent J 1983; 155: 308-10.
39. Hirsh J, Dalen J, Deykin D, Poller L, Bussy H. Oral anticoagulants. Mechanism of action, c1inical efectiveness and optimal therapeutic range. Chest 1995; 108: 231S-46S.
40. Steinberg M, Moores JI. Use of INR to asses degree of anticoagulation in patients who have dental procedures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 80: 175-7.
41. Little JW, Falace DA, Miller CS, Rhodus NL. Trastornos hemorrágicos. En: Tratamiento odontológico del paciente bajo tratamiento médico. 5ta ed. Madrid: Harcourt Brace de España; 1998. p. 466-94.
42. Martínes-Sanz J, Brescó-Salinas M, Berini-Aytés L, Gay Escoda C. Cirugía bucal y anticoagulants orales: una propuesta de actuación. RCOE 1998; 3: 555-62.
43. Halfpenny W, Fraser JS, Adlam DM. Comparison of 2 hemostatic agents for the prevention of postextraction hemorrhage in patients on anticoagulants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 257-9.
44. Crispian S, Andy G. Oral surgery in patients on anticoagulant therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 94: 57-64.
45. González R, Lozano ML, Moraleda JM. Diagnóstico de los trastornos de la hemostasia. En: Moraleda JM, editor. Hematología. Madrid: Luzán 5, S.A; 1996. p. 459-69.